Literature DB >> 19519400

Hypoxic tumor microenvironment and cancer cell differentiation.

Yuri Kim1, Qun Lin, Peter M Glazer, Zhong Yun.   

Abstract

Hypoxia or oxygen deficiency is a salient feature of solid tumors. Hypoxic tumors are often resistant to conventional cancer therapies, and tumor hypoxia correlates with advanced stages of malignancy. Hypoxic tumors appear to be poorly differentiated. Increasing evidence suggests that hypoxia has the potential to inhibit tumor cell differentiation and thus plays a direct role in the maintenance of cancer stem cells. Studies have also shown that hypoxia blocks differentiation of mesenchymal stem/progenitor cells, a potential source of tumor-associated stromal cells. It is therefore likely that hypoxia may have a profound impact on the evolution of the tumor stromal microenvironment. These observations have led to the emergence of a novel paradigm for a role of hypoxia in facilitating tumor progression. Hypoxia may help create a microenvironment enriched in poorly differentiated tumor cells and undifferentiated stromal cells. Such an undifferentiated hypoxic microenvironment may provide essential cellular interactions and environmental signals for the preferential maintenance of cancer stem cells. This hypothesis suggests that effectively targeting hypoxic cancer stem cells is a key to successful tumor control.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19519400      PMCID: PMC2824923          DOI: 10.2174/156652409788167113

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  146 in total

1.  Oct-3/4 is a dose-dependent oncogenic fate determinant.

Authors:  Sharon Gidekel; Galina Pizov; Yehudit Bergman; Eli Pikarsky
Journal:  Cancer Cell       Date:  2003-11       Impact factor: 31.743

2.  Significant correlation of hypoxia-inducible factor-1alpha with treatment outcome in cervical cancer treated with radical radiotherapy.

Authors:  Philipp Burri; Valentin Djonov; Daniel M Aebersold; Katja Lindel; Ueli Studer; Hans J Altermatt; Luca Mazzucchelli; Richard H Greiner; Günther Gruber
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-06-01       Impact factor: 7.038

Review 3.  The hypoxic tumour microenvironment and metastatic progression.

Authors:  Patrick Subarsky; Richard P Hill
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

4.  Oxygenation gain factor: a novel parameter characterizing the association between hemoglobin level and the oxygenation status of breast cancers.

Authors:  Peter Vaupel; Arnulf Mayer; Susanne Briest; Michael Höckel
Journal:  Cancer Res       Date:  2003-11-15       Impact factor: 12.701

5.  Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL.

Authors:  Peter Staller; Jitka Sulitkova; Joanna Lisztwan; Holger Moch; Edward J Oakeley; Wilhelm Krek
Journal:  Nature       Date:  2003-09-18       Impact factor: 49.962

Review 6.  Prognostic significance of tumor oxygenation in humans.

Authors:  Sydney M Evans; Cameron J Koch
Journal:  Cancer Lett       Date:  2003-05-30       Impact factor: 8.679

Review 7.  Targeting HIF-1 for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

8.  Hypoxia and differentiation in squamous cell carcinomas of the uterine cervix: pimonidazole and involucrin.

Authors:  Yoshihiro Azuma; Shu-Chuan Chou; Ruth A Lininger; Brian J Murphy; Mahesh A Varia; James A Raleigh
Journal:  Clin Cancer Res       Date:  2003-10-15       Impact factor: 12.531

9.  Identification of a cancer stem cell in human brain tumors.

Authors:  Sheila K Singh; Ian D Clarke; Mizuhiko Terasaki; Victoria E Bonn; Cynthia Hawkins; Jeremy Squire; Peter B Dirks
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

10.  Regulation of the chemokine receptor CXCR4 by hypoxia.

Authors:  Tiziana Schioppa; Badarch Uranchimeg; Alessandra Saccani; Subhra K Biswas; Andrea Doni; Annamaria Rapisarda; Sergio Bernasconi; Simona Saccani; Manuela Nebuloni; Luca Vago; Alberto Mantovani; Giovanni Melillo; Antonio Sica
Journal:  J Exp Med       Date:  2003-11-03       Impact factor: 14.307

View more
  52 in total

1.  DLK1, delta-like 1 homolog (Drosophila), regulates tumor cell differentiation in vivo.

Authors:  Asma Begum; Yuri Kim; Qun Lin; Zhong Yun
Journal:  Cancer Lett       Date:  2011-12-03       Impact factor: 8.679

Review 2.  Tumor heterogeneity and its implication for drug delivery.

Authors:  Tracy A Denison; You Han Bae
Journal:  J Control Release       Date:  2012-04-15       Impact factor: 9.776

3.  Differential hypoxic regulation of hypoxia-inducible factors 1alpha and 2alpha.

Authors:  Qun Lin; Xiangyu Cong; Zhong Yun
Journal:  Mol Cancer Res       Date:  2011-05-13       Impact factor: 5.852

Review 4.  Proteinaceous Hydrogels for Bioengineering Advanced 3D Tumor Models.

Authors:  Barbara Blanco-Fernandez; Vítor M Gaspar; Elisabeth Engel; João F Mano
Journal:  Adv Sci (Weinh)       Date:  2021-01-04       Impact factor: 16.806

Review 5.  Strategies for isolating and enriching cancer stem cells: well begun is half done.

Authors:  Jiang-Jie Duan; Wen Qiu; Sen-Lin Xu; Bin Wang; Xian-Zong Ye; Yi-Fang Ping; Xia Zhang; Xiu-Wu Bian; Shi-Cang Yu
Journal:  Stem Cells Dev       Date:  2013-05-09       Impact factor: 3.272

Review 6.  Targeting gut microbiota in hepatocellular carcinoma: probiotics as a novel therapy.

Authors:  Murphy L Y Wan; Hani El-Nezami
Journal:  Hepatobiliary Surg Nutr       Date:  2018-02       Impact factor: 7.293

Review 7.  Tumor Microenvironment in Head and Neck Squamous Cell Carcinomas.

Authors:  Görkem Eskiizmir
Journal:  Turk Arch Otorhinolaryngol       Date:  2015-09-01

8.  Role of oxygen consumption in hypoxia protection by translation factor depletion.

Authors:  Barbara Scott; Chun-Ling Sun; Xianrong Mao; Cong Yu; Bhupinder P S Vohra; Jeffrey Milbrandt; C Michael Crowder
Journal:  J Exp Biol       Date:  2013-03-26       Impact factor: 3.312

9.  High expression of miR-9 in CD133+ glioblastoma cells in chemoresistance to temozolomide.

Authors:  Jessian L Munoz; Vivian Rodriguez-Cruz; Pranela Rameshwar
Journal:  J Cancer Stem Cell Res       Date:  2015-02-27

Review 10.  Enhanceosomes as integrators of hypoxia inducible factor (HIF) and other transcription factors in the hypoxic transcriptional response.

Authors:  Matthew R Pawlus; Cheng-Jun Hu
Journal:  Cell Signal       Date:  2013-05-21       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.